A Study of Palbociclib With Exemestane Plus GnRH Versus Capecitabine in Premenopausal Women With HR+ MBC
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Palbociclib|DRUG: Exemestane|DRUG: Leuprolide Acetate|DRUG: Capecitabine
Sponsor: Samsung Medical Center